| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |